Induction of tamoxifen resistance in breast cancer cells by ELF electromagnetic fields

Biochemical and Biophysical Research Communications

Volumn 336, Issue 4, 2005, Pages 1144-1149

  Girgert, Rainer ^a   Schimming, Hartmut ^b   Körner, Wolfgang ^c   Gründker, Carsten ^a   Hanf, Volker ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c Bavarian Environment Agency   (Germany)

Author keywords

Breast cancer; Dose response; Electromagnetic fields; Estrogen receptor; Tamoxifen resistance

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CALCULATION; CANCER CELL CULTURE; CELL CLONE; CELL STRAIN MCF 7; CLINICAL OBSERVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG SENSITIVITY; ELECTROMAGNETIC FIELD; HUMAN; HUMAN CELL; HYPOTHESIS; IC 50; LONG TERM CARE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; ELECTROMAGNETIC FIELDS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; TAMOXIFEN;

MINK CELL FOCUS-FORMING VIRUS;

EID: 25644459872     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.243     Document Type: Article

References (35)

1. J. Schüz, J.P. Grigat, K. Brinkmann, and J. Michaelis Residential magnetic fields as a risk factor for childhood acute leukaemia: results from a German population-based case-control study Int. J. Cancer 91 2001 728 735
2. N. Wertheimer, and E. Leeper Adult cancer related to electrical wires near the home Int. J. Epidemiol. 11 1982 345 355
3. M. Feychting, U. Forssen, L.E. Rutqvist, and A. Ahlbom Magnetic fields and breast cancer in Swedish adults residing near high-voltage power lines Epidemiology 9 1998 392 397
4. P.K. Verkasalo, E. Pukkala, J. Kaprio, K.V. Heikkila, and M. Koskenvuo Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study BMJ 313 1996 1047 1051
5. C.Y. Li, G. Theriault, and R.S. Lin Residential exposure to 60-Hertz magnetic fields and adult cancers in Taiwan Epidemiology 8 1997 25 30
6. S. Thun-Battersby, M. Mevissen, and W. Loscher Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer Cancer Res. 59 1999 3627 3633
7. H. Lai, and N.P. Singh Magnetic field induced DNA strand breaks in brain cells of the rat Environ. Health Perspect. 112 2004 687 694
8. R.G. Stevens, and S. Davis The melatonin hypothesis: electric power and breast cancer Environ. Health Perspect. 104 Suppl. 1 1996 135 140
9. W.S. Baldwin, and J.C. Barrett Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers Mol. Carcinog. 21 1998 149 155
10. D.E. Blask, and S.M. Hill Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture J. Neural Transm. Suppl. 21 1986 433 449
11. R.P. Liburdy, T.R. Sloma, R. Sokolic, and P. Yaswen ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation J. Pineal Res. 14 1993 89 97
12. C.F. Blackman, S.G. Benane, and D.E. House The influence of 1.2 microT, 60 Hz magnetic fields on melatonin- and tamoxifen-induced inhibition of MCF-7 cell growth Bioelectromagnetics 22 2001 122 128
13. M. Ishido, H. Nitta, and M. Kabuto Magnetic fields (MF) of 50 Hz at 1.2 microT as well as 100 microT cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin 1a receptor in MF-sensitive MCF-7 cells Carcinogenesis 22 2001 1043 1048
14. J.D. Harland, and R.P. Liburdy Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line Bioelectromagnetics 18 1997 555 562
15. I.A. Jaiyesimi, A.U. Buzdar, D.A. Decker, and G.N. Hortobagyi Use of tamoxifen for breast cancer: 28 years later J. Clin. Oncol. 13 1995 513 529
16. R. Girgert, C. Bartsch, S.M. Hill, R. Kreienberg, and V. Hanf Tracking the elusive antineoplastic effect of melatonin: a new methodological approach Neuroendocrinol. Lett. 24 2003 433 437
17. T.A. Litovitz, C.J. Montrose, and W. Wang Dose-response implications of the transient nature of electromagnetic field induced bioeffects Bioelectromagnetics Suppl. 1 1992 237 246
18. R.E. Curtis, J. Boice, D.A. Shriner, B.F. Hankey, and J.F. Fraumeni Second cancers after adjuvant tamoxifen therapy for breast cancer J. Natl. Cancer Inst. 88 1996 832 834
19. L.R. Wiseman, M.D. Johnson, A.E. Wakeling, A.E. Lykkesfeldt, F.E. May, and B.R. Westley Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells Eur. J. Cancer A 29 1993 2256 2264
20. C.M.W. Chan, A.E. Lykkesfeldt, M.G. Parker, and M. Dowsett Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140 and corepressor SMRT in tamoxifen-resistant breast cancer Clin. Cancer Res. 5 1999 3460 3467
21. N.J. McKenna, R.B. Lanz, and B.W. O'Malley Nuclear receptor coregulators: cellular and molecular biology Endocr. Rev. 20 1999 321 344
22. E.M.J.J. Berns, I.L. van Staveren, J.G.M. Klijn, and J.A. Foekens Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer Breast Cancer Res. Treat. 48 1998 87 92
23. I. Girault, F. Lerebours, and S. Amarir Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that N-CoR 1 expression is predictive of the response to tamoxifen Clin. Cancer Res. 9 2003 1259 1266
24. V. Speirs, A.T. Parkes, M.J. Kerin, D.S. Walton, P.J. Carelton, J.N. Fox, and S.L. Atkin Coexpression of estrogen receptor α and β: poor prognostic factors in human breast cancer Cancer Res. 59 1999 525 528
25. S. Davis, W.T. Kaune, D.K. Mirick, C. Chen, and R.G. Stevens Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women Am. J. Epidemiol. 154 2001 591 600
26. A. De Cupis, and R.E. Favoni Oestrogen/growth factor cross-talk in breast carcinoma: a specific target for novel antioestrogens TIPS 18 1997 245 251
27. R. Goodman, L.X. Wei, J. Bumann, and A. Henderson Exposure to electric and magnetic (EM) fields increases transcripts in HL-60 cells: does adaptation to EM fields occur? Bioelectrochem. Bioenerg. 29 1992 185 192
28. R.D. Owen MYC mRNA abundance is unchanged in subcultures of HL60 cells exposed to power-line frequency magnetic fields Radiat. Res. 150 1998 23 30
29. L.I. Loberg, J.R. Gauger, J.L. Buthod, W.R. Engdahl, and D.L. McCormick Gene expression in human breast epithelial cells exposed to 60 Hz magnetic fields Carcinogenesis 20 1999 1633 1636
30. M. Mevissen, M. Kietzmann, and W. Löscher In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA Cancer Lett. 90 1995 207 214
31. J.M. Mullins, L.M. Penafiel, J. Juutilainen, and T.A. Litovitz Dose-response of electromagnetic field-enhanced ornithine decarboxylase activity Bioelectrochem. Bioenerg. 48 1999 193 199
32. G.A. Boorman, R.D. Owen, W.G. Lotz, and M.J. Galvin Jr. Evaluation of in vitro effects of 50 and 60 Hz magnetic fields in regional EMF exposure facilities Radiat. Res. 153 2000 648 657
33. A. DiCarlo, N. White, F. Guo, P. Garrett, and T. Litovitz Chronic electromagnetic field exposure decreases HSP70 levels and lowers cytoprotection J. Cell. Biochem. 84 2002 447 454
34. B. Shi, B. Farboud, R. Nuccitelli, and R.R. Isseroff Power-line frequency electromagnetic fields do not induce changes in phosphorylation, localization, or expression of the 27-kilodalton heat shock protein in human keratinocytes Environ. Health Perspect. 111 2003 181 188
35. H. Lin, M. Blank, K. Rossol-Haseroth, and R. Goodman Regulating genes with electromagnetic response elements J. Cell. Biochem. 81 2001 143 148